145 Views | 135 Downloads
Correspondence: Dr. Kristin N. Nelson, Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30312 (e-mail: knbratt@emory.edu)
Disclosures: B.A.L. reports receiving personal fees from Takeda Pharmaceutical Company Ltd. (Tokyo, Japan), the CDC Foundation (Atlanta, Georgia), and Hall Booth Smith, P.C. (Atlanta, Georgia) outside of this work. None of the other authors have any conflicts of interest to declare.
This study was primarily funded by the National Institute of Allergy and Infectious Diseases, US National Institutes of Health (grants R01AI138783 (Principal Investigator (PI): S.M.J.), R01AI089349 (PI: N.R.G.), R01AI087465 (PI: N.R.G.), and R01AI138646 (PI: N.R.G.)).
It was also supported in part by the National Institute of Allergy and Infectious Diseases (grants R01AI114304 (PI: J.C.M.B.), K24AI114444 (PI: N.R.G.), and K23AI134182 (PI: S.C.A.))
Emory Center for AIDS Research (grant P30AI050409 (PI: James Curran)), the Einstein Center for AIDS Research (grant P30AI124414 (PI: Harris Goldstein)), and the Einstein/Montefiore Institute for Clinical and Translational Research (grant UL1 TR001073 (PI: Harry Shamoon)).
© Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2020.